CONSEQUENCES OF DOPAMINERGIC AGONIST ASSOCIATED WITH BDNF TREATMENT ON BEHAVIORAL ALTERATIONS AND CYTOLOGICAL CHANGES IN AN EXPERIMENTAL MODEL OF PARKINSON DISEASE DUE TO MANGANESE EXPOSURE.
M. Teresa Ibarra-Gutiearrez, Veronica Anaya-Martinez, Ana L. Gutierrez-Valdez, Jose Luis Ordonez-Librado, Daniel Martinez-Fong, Jorge Aceves-Ruiz, Javier Sanchez-Betancourt, Leonardo Reynoso-Erazo, Enrique Montiel-Flores, Rocio Tron-Alvarez and *Maria Rosa Avila-Costa.
DOI URL: http://dx.doi.org/10.21474/IJAR01/6501